---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-001035"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2022-02-11T23:59:59+00:00"
generated_at: "2026-06-27T08:49:20.714747+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Gen. H.R. McMaster to retire from NRX Pharmaceuticals Board at next annual meeting

## Summary
- Gen. McMaster informed the Board on Feb 7, 2022 that he will retire effective the next Annual Meeting.
- His term would have expired in 2024; he will continue as director until the Annual Meeting.
- No disagreement with the Company cited; McMaster will remain as an advisor.
- Board thanked McMaster for service; company developing NRX-101 for suicidal depression and PTSD.

## SEC filing metadata
- accession: 0001558370-22-001035
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2022-02-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/0001558370-22-001035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/nrxp-20220211x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-001035
- JSON: https://secwatch.observer/filing/0001558370-22-001035.json
- Plain text: https://secwatch.observer/filing/0001558370-22-001035.txt

## Key facts
- Executive change
  Gen. H.R. McMaster departed as director at NRX Pharmaceuticals, Inc..
  - Action: retiring
  - Role: director
  source text: On February 7, 2022, one of the Company’s directors Gen. H.R. McMaster informed the Board that he would be retiring from the Board with effect from the next Annual Meeting of Shareholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/0001558370-22-001035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.